An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) is now available. ResMed Inc. has filed its ...

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor ...

Nanosonics chief executive Michael Kavanagh says the government should step in and help domestic development, a sentiment ...

Medical device company ResMed (NYSE:RMD) in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit ...

Resmed says that U.S. Customs and Border Protection has confirmed that its devices will continue to be exempt from tariffs ...

Australian sleep health giant Resmed has locked down an exemption from Donald Trump’s sweeping trade tariffs. Resmed produces ...

A major Australian company has managed to secure a tariff exemption from the Trump Administration as the world waits to see ...

Resmed has named Salli Schwartz as chief investor relations officer, where she will lead the company’s global investor relations function and report to Mick Farrell, chairman of the board ...

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near-term risk from this therapy due to the higher cost and invasive surgery ...

In a report released today, Adam Maeder from Piper Sandler maintained a Hold rating on Resmed (RMD – Research Report), with a price target of ...

Australian sleep device giant ResMed has secured an exemption from Donald Trump’s global tariffs in a major win for the ...

The healthcare sector, up 1.2%, was boosted by a strong third-quarter result from sleep health company Resmed. Materials also ...